ミズクリニックメイワン開院以降の論文業績（2026年5月13日現在）

クリニック開院6年間で81編の論文を国際雑誌に掲載し、世界中の研究者および臨床医と情報共有し、最先端の治療法を患者さんに提供するため、日夜努力しております。

2025年

Kobayashi H, Shigetomi H, Nishio M, Umetani M, Imanaka S, Hashimoto H.
Molecular Regulation of FOXO1 and Its Pathophysiological Significance in Endometriosis: A Narrative Review.
Antioxidants (Basel). 2025 Dec 19;15(1):3. doi: 10.3390/antiox15010003. PMID: 41596062; PMCID: PMC12838002.

Shigetomi H, Nishio M, Umetani M, Imanaka S, Hashimoto H, Kobayashi H.
Balancing Decidualization, Autophagy, and Cellular Senescence for Reproductive Success in Endometriosis Biology.
Int J Mol Sci. 2025 Sep 18;26(18):9125. doi: 10.3390/ijms26189125. PMID: 41009686; PMCID: PMC12471044.

Kobayashi H, Shigetomi H, Nishio M, Umetani M, Imanaka S, Hashimoto H.
Regulatory Interplay of p53, AMPK, and mTOR in Decidualization: Implications for Reproductive Competence and Cancer Biology.
Reprod Sci. 2025 Oct;32(10):3198-3220. doi: 10.1007/s43032-025-01970-z. Epub 2025 Sep 4. PMID: 40908401.

Kobayashi H, Imanaka S.
Endometriosis-related infertility focusing on mitochondrial DNA damage and its repair mechanism: Considering treatment strategies.
J Obstet Gynaecol Res. 2025 Jul;51(7):e16358. doi: 10.1111/jog.16358. PMID: 40583553.

Kobayashi H, Umetani M, Nishio M, Shigetomi H, Imanaka S, Hashimoto H.
Molecular Mechanisms of Cellular Senescence in Age-Related Endometrial Dysfunction.
Cells. 2025 Jun 6;14(12):858. doi: 10.3390/cells14120858. PMID: 40558485; PMCID: PMC12190264.

Kobayashi H, Nishio M, Umetani M, Shigetomi H, Imanaka S, Hashimoto H.
Endometrial Aging and Reproductive Decline: The Central Role of Mitochondrial Dysfunction.
Int J Mol Sci. 2025 May 24;26(11):5060. doi: 10.3390/ijms26115060. PMID: 40507871; PMCID: PMC12154470.

Kobayashi H, Imanaka S.
Understanding the impact of mitochondrial DNA mutations on aging and carcinogenesis (Review).
Int J Mol Med. 2025 Aug;56(2):118. doi: 10.3892/ijmm.2025.5559. Epub 2025 Jun 6. PMID: 40476552; PMCID: PMC12176274.

Kobayashi H, Shigetomi H, Imanaka S.
Reassessing the Role of Tissue Factor Pathway Inhibitor 2 in Neoplastic and Non-Neoplastic Lesions.
Cancers (Basel). 2025 Apr 25;17(9):1447. doi: 10.3390/cancers17091447. PMID: 40361374; PMCID: PMC12071115.

Ogawara Y, Yokota NR, Yamada Y, Arakawa N, Sakamaki K, Kobayashi H, Kubota K, Kimura F, Mizushima T, Yamazaki E, Miyagi E.
Assessment of tissue factor pathway inhibitor 2 (TFPI2) as a novel serum marker for malignant tumors of the ovary before and after treatment: A case-control study.
J Obstet Gynaecol Res. 2025 Feb;51(2):e16241. doi: 10.1111/jog.16241. PMID: 39971476; PMCID: PMC11839307.

Kobayashi H, Matsubara S, Yoshimoto C, Shigetomi H, Imanaka S.
A Comprehensive Review of the Contribution of Mitochondrial DNA Mutations and Dysfunction in Polycystic Ovary Syndrome, Supported by Secondary Database Analysis.
Int J Mol Sci. 2025 Jan 29;26(3):1172. doi: 10.3390/ijms26031172. PMID: 39940939; PMCID: PMC11818232.

Kobayashi H, Imanaka S.
Exploring potential pathways from oxidative stress to ovarian aging.
J Obstet Gynaecol Res. 2025 Jan;51(1):e16166. doi:10.1111/jog.16166. Epub 2024 Nov 21. PMID: 39572911.

2024年

Kobayashi H, Imanaka S.
Reevaluating the variation of cesarean scar defect.
J Obstet Gynaecol Res. 2024 Dec;50(12):2169-2177. doi: 10.1111/jog.16137. Epub 2024 Nov 5. PMID: 39497572.

Kobayashi H, Imanaka S.
Recent progress in metabolomics for analyzing common infertility conditions that affect ovarian function.
Reprod Med Biol. 2024 Sep 30;23(1):e12609. doi: 10.1002/rmb2.12609. PMID: 39351127; PMCID: PMC11442066.

Kobayashi H, Imanaka S, Yoshimoto C, Matsubara S, Shigetomi H.
Rethinking the pathogenesis of endometriosis: Complex interactions of genomic, epigenetic, and environmental factors.
J Obstet Gynaecol Res. 2024 Oct;50(10):1771-1784. doi: 10.1111/jog.16089. Epub 2024 Sep 18. PMID: 39293995.

Kobayashi H, Imanaka S, Yoshimoto C, Matsubara S, Shigetomi H.
Role of autophagy and ferroptosis in the development of endometriotic cysts (Review).
Int J Mol Med. 2024 Sep;54(3):78. doi: 10.3892/ijmm.2024.5402. Epub 2024 Jul 12. PMID: 38994772; PMCID: PMC11265838.

Kawahara N, Kobayashi H, Maehana T, Iwai K, Yamada Y, Kawaguchi R, Takahama J, Marugami N, Nishi H, Sakai Y, Takano H, Seki T, Yokosu K, Hirata Y, Yoshida K, Ujihira T, Kimura F.
MR Relaxometry for Discriminating Malignant Ovarian Cystic Tumors: A Prospective Multicenter Cohort Study.
Diagnostics (Basel). 2024 May 21;14(11):1069. doi: 10.3390/diagnostics14111069. PMID: 38893596; PMCID: PMC11172376.

Kobayashi H, Imanaka S, Yoshimoto C, Matsubara S, Shigetomi H.
Molecular mechanism of autophagy and apoptosis in endometriosis: Current understanding and future research directions.
Reprod Med Biol. 2024 Apr 20;23(1):e12577. doi: 10.1002/rmb2.12577. PMID: 38645639; PMCID: PMC11031673.

Kobayashi H, Matsubara S, Yoshimoto C, Shigetomi H, Imanaka S.
Current understanding of the pathogenesis of placenta accreta spectrum disorder with focus on mitochondrial function.
J Obstet Gynaecol Res. 2024 Jun;50(6):929-940. doi: 10.1111/jog.15936. Epub 2024 Mar 27. PMID: 38544343.

Kobayashi H, Shigetomi H, Matsubara S, Yoshimoto C, Imanaka S.
Role of the mitophagy-apoptosis axis in the pathogenesis of polycystic ovarian syndrome.
J Obstet Gynaecol Res. 2024 May;50(5):775-792. doi: 10.1111/jog.15916. Epub 2024 Feb 28. PMID: 38417972.

Kobayashi H, Yoshimoto C, Matsubara S, Shigetomi H, Imanaka S.
An integral role of mitochondrial function in the pathophysiology of preeclampsia.
Mol Biol Rep. 2024 Feb 23;51(1):330. doi: 10.1007/s11033-024-09285-z. PMID: 38393449.

Kobayashi H, Yoshimoto C, Matsubara S, Shigetomi H, Imanaka S.
Altered Energy Metabolism, Mitochondrial Dysfunction, and Redox Imbalance Influencing Reproductive Performance in Granulosa Cells and Oocyte During Aging.
Reprod Sci. 2024 Apr;31(4):906-916. doi: 10.1007/s43032-023-01394-7. Epub 2023 Nov 2. PMID: 37917297.

2023年

Kobayashi H, Yoshimoto C, Matsubara S, Shigetomi H, Imanaka S.
A comprehensive overview of recent developments on the mechanisms and pathways of ferroptosis in cancer: the potential implications for therapeutic strategies in ovarian cancer.
Cancer Drug Resist. 2023 Aug 11;6(3):547-566. doi: 10.20517/cdr.2023.49. PMID: 37842240; PMCID: PMC10571061.

Kobayashi H, Matsubara S, Yoshimoto C, Shigetomi H, Imanaka S.
The role of mitochondrial dynamics in the pathophysiology of endometriosis.
J Obstet Gynaecol Res. 2023 Dec;49(12):2783-2791. doi: 10.1111/jog.15791. Epub 2023 Sep 8. PMID: 37681703.

Kobayashi H, Imanaka S.
Understanding Ultrasound Features that Predict Symptom Severity in Patients with Adenomyosis: a Systematic Review.
Reprod Sci. 2024 Feb;31(2):320-331. doi: 10.1007/s43032-023-01318-5. Epub 2023 Aug 16. PMID: 37584856.

Kobayashi H, Matsubara S, Yoshimoto C, Shigetomi H, Imanaka S.
Tissue factor pathway inhibitor 2: Current understanding, challenges, and future perspectives.
J Obstet Gynaecol Res. 2023 Nov;49(11):2575-2583. doi: 10.1111/jog.15770. Epub 2023 Aug 7. PMID: 37549932.

Kobayashi H.
Gut and reproductive tract microbiota: Insights into the pathogenesis of endometriosis (Review).
Biomed Rep. 2023 May 29;19(1):43. doi: 10.3892/br.2023.1626. PMID: 37324168; PMCID: PMC10265574.

Kobayashi H, Yoshimoto C, Matsubara S, Shigetomi H, Imanaka S.
Current Understanding of and Future Directions for Endometriosis-Related Infertility Research with a Focus on Ferroptosis.
Diagnostics (Basel). 2023 May 31;13(11):1926. doi: 10.3390/diagnostics13111926. PMID: 37296777; PMCID: PMC10252275.

Kobayashi H, Matsubara S, Yoshimoto C, Shigetomi H, Imanaka S.
Tissue Factor Pathway Inhibitors as Potential Targets for Understanding the Pathophysiology of Preeclampsia.
Biomedicines. 2023 Apr 22;11(5):1237. doi: 10.3390/biomedicines11051237. PMID: 37238908; PMCID: PMC10215522.

Kobayashi H.
Clinicopathological characteristics, molecular features and novel diagnostic strategies for the detection of malignant transformation of endometriosis (Review).
Exp Ther Med. 2023 Apr 24;25(6):279. doi: 10.3892/etm.2023.11978. PMID: 37206546; PMCID: PMC10189589.

Kobayashi H, Matsubara S, Imanaka S.
The role of tissue factor pathway inhibitor 2 in the coagulation and fibrinolysis system.
J Obstet Gynaecol Res. 2023 Jul;49(7):1677-1683. doi: 10.1111/jog.15660. Epub 2023 Apr 25. PMID: 37186495.

Kobayashi H.
Similarities in Pathogenetic Mechanisms Underlying the Bidirectional Relationship between Endometriosis and Pelvic Inflammatory Disease.
Diagnostics (Basel). 2023 Feb 24;13(5):868. doi: 10.3390/diagnostics13050868. PMID: 36900012; PMCID: PMC10000848.

Kobayashi H.
Endometrial Inflammation and Impaired Spontaneous Decidualization: Insights into the Pathogenesis of Adenomyosis.
Int J Environ Res Public Health. 2023 Feb 20;20(4):3762. doi: 10.3390/ijerph20043762. PMID: 36834456; PMCID: PMC9964052.

Kobayashi H.
Efficacy, Adverse Events, and Challenges of Dienogest in the Management of Symptomatic Adenomyosis: A Comparison with Different Hormonal Treatments.
Gynecol Obstet Invest. 2023;88(2):71-80. doi: 10.1159/000529185. Epub 2023 Jan 20. PMID: 36682346.

2022年

Kobayashi H, Yamada Y.
Efficacy of oral ferric citrate hydrate treatment for anemia caused by niraparib: a case report.
J Med Case Rep. 2022 Nov 25;16(1):440. doi: 10.1186/s13256-022-03666-3. PMID: 36424618; PMCID: PMC9694605.

Kobayashi H.
Recent advances in understanding the metabolic plasticity of ovarian cancer: A systematic review.
Heliyon. 2022 Nov 11;8(11):e11487. doi: 10.1016/j.heliyon.2022.e11487. PMID: 36406733; PMCID: PMC9668530.

Kawahara N, Kawaguchi R, Maehana T, Yamanaka S, Yamada Y, Kobayashi H, Kimura F.
The Endometriotic Neoplasm Algorithm for Risk Assessment (e-NARA) Index Sheds Light on the Discrimination of Endometriosis-Associated Ovarian Cancer from Ovarian Endometrioma.
Biomedicines. 2022 Oct 24;10(11):2683. doi: 10.3390/biomedicines10112683. PMID: 36359203; PMCID: PMC9687708.

Kobayashi H, Imanaka S.
Understanding the molecular mechanisms of macrophage polarization and metabolic reprogramming in endometriosis: A narrative review.
Reprod Med Biol. 2022 Oct 17;21(1):e12488. doi: 10.1002/rmb2.12488. PMID: 36310658; PMCID: PMC9596393.

Kobayashi H.
Molecular Targets for Nonhormonal Treatment Based on a Multistep Process of Adenomyosis Development.
Reprod Sci. 2023 Mar;30(3):743-760. doi: 10.1007/s43032-022-01036-4. Epub 2022 Jul 15. PMID: 35838920.

Shigemitsu A, Naruse K, Kobayashi H.
Hypoxia Promotes Extravillous Trophoblast Cell Invasion through the Hypoxia-Inducible Factor Urokinase-Type Plasminogen Activator Receptor Pathway.
Gynecol Obstet Invest. 2022;87(3-4):232-241. doi: 10.1159/000525851. Epub 2022 Jul 4. PMID: 35785760.

Kobayashi H, Yamada Y, Kawaguchi R, Ootake N, Myoba S, Kimura F.
Tissue factor pathway inhibitor 2: A potential diagnostic marker for discriminating benign from malignant ovarian tumors.
J Obstet Gynaecol Res. 2022 Sep;48(9):2442-2451. doi: 10.1111/jog.15345. Epub 2022 Jul 1. PMID: 35778814.

Yamanaka S, Kawahara N, Kawaguchi R, Waki K, Maehana T, Fukui Y, Miyake R, Yamada Y, Kobayashi H, Kimura F.
The Comparison of Three Predictive Indexes to Discriminate Malignant Ovarian Tumors from Benign Ovarian Endometrioma: The Characteristics and Efficacy.
Diagnostics (Basel). 2022 May 12;12(5):1212. doi: 10.3390/diagnostics12051212. PMID: 35626367; PMCID: PMC9140823.

Yamanaka S, Miyake R, Yamada Y, Kawaguchi R, Ootake N, Myoba S, Kobayashi H.
Tissue Factor Pathway Inhibitor 2: A Novel Biomarker for Predicting Asymptomatic Venous Thromboembolism in Patients with Epithelial Ovarian Cancer.
Gynecol Obstet Invest. 2022;87(2):133-140. doi: 10.1159/000524804. Epub 2022 May 25. PMID: 35613543.

Ogawa K, Liu T, Kawahara N, Kobayashi H.
Macrophages Protect Endometriotic Cells Against Oxidative Damage Through a Cross-Talk Mechanism.
Reprod Sci. 2022 Aug;29(8):2165-2178. doi: 10.1007/s43032-022-00890-6. Epub 2022 Feb 23. PMID: 35199318.

Kobayashi H, Imanaka S, Shigetomi H.
Revisiting therapeutic strategies for ovarian cancer by focusing on redox homeostasis.
Oncol Lett. 2022 Mar;23(3):80. doi: 10.3892/ol.2022.13200. Epub 2022 Jan 11. PMID: 35111249; PMCID: PMC8771630.

Miyake R, Yamada Y, Yamanaka S, Kawaguchi R, Ootake N, Myoba S, Kobayashi H.
Tissue factor pathway inhibitor 2 as a serum marker for diagnosing asymptomatic venous thromboembolism in patients with epithelial ovarian cancer and positive D-dimer results.
Mol Clin Oncol. 2022 Feb;16(2):46. doi: 10.3892/mco.2021.2479. Epub 2021 Dec 23. PMID: 35003744; PMCID: PMC8739701.

2021年

Kobayashi H, Shigetomi H, Imanaka S.
Nonhormonal therapy for endometriosis based on energy metabolism regulation.
Reprod Fertil. 2021 Nov 25;2(4):C42-C57. doi: 10.1530/RAF-21-0053. PMID: 35118411; PMCID: PMC8788578.

Shigetomi H, Imanaka S, Kobayashi H.
Effects of iron-related compounds and bilirubin on redox homeostasis in endometriosis and its malignant transformations.
Horm Mol Biol Clin Investig. 2021 Dec 2;43(2):187-192. doi: 10.1515/hmbci-2021-0065. PMID: 34854656.

Imanaka S, Shigetomi H, Kawahara N, Kobayashi H.
Clinicopathological characteristics and imaging findings to identify adenomyosis-related symptoms.
Reprod Med Biol. 2021 Aug 22;20(4):435-443. doi: 10.1002/rmb2.12409. PMID: 34646071; PMCID: PMC8499601.

Nakamura E, Kobayashi K, Sekizawa A, Kobayashi H, Takai Y; Medical Safety and Education Committee of the Japan Association of Obstetricians and Gynecologists (JAOG), Tokyo, Japan.
Survey on spontaneous miscarriage and induced abortion surgery safety at less than 12 weeks of gestation in Japan.
J Obstet Gynaecol Res. 2021 Dec;47(12):4158-4163. doi: 10.1111/jog.15014. Epub 2021 Sep 27. PMID: 34571569.

Hamanishi J, Takeshima N, Katsumata N, Ushijima K, Kimura T, Takeuchi S, Matsumoto K, Ito K, Mandai M, Nakai H, Sakuragi N, Watari H, Takahashi N, Kato H, Hasegawa K, Yonemori K, Mizuno M, Takehara K, Niikura H, Sawasaki T, Nakao S, Saito T, Enomoto T, Nagase S, Suzuki N, Matsumoto T, Kondo E, Sonoda K, Aihara S, Aoki Y, Okamoto A, Takano H, Kobayashi H, Kato H, Terai Y, Takazawa A, Takahashi Y, Namba Y, Aoki D, Fujiwara K, Sugiyama T, Konishi I.
Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA).
J Clin Oncol. 2021 Nov 20;39(33):3671-3681. doi: 10.1200/JCO.21.00334. Epub 2021 Sep 2. PMID: 34473544; PMCID: PMC8601279.

Kawahara N, Miyake R, Yamanaka S, Kobayashi H.
A Novel Predictive Tool for Discriminating Endometriosis Associated Ovarian Cancer from Ovarian Endometrioma: The R2 Predictive Index.
Cancers (Basel). 2021 Jul 29;13(15):3829. doi: 10.3390/cancers13153829. PMID: 34359728; PMCID: PMC8345171.

Kobayashi H, Matsubara S, Imanaka S.
Clinicopathological features of different subtypes in adenomyosis: Focus on early lesions.
PLoS One. 2021 Jul 14;16(7):e0254147. doi: 10.1371/journal.pone.0254147. PMID: 34260636; PMCID: PMC8279363.

Kobayashi H, Imanaka S.
Toward an understanding of tissue factor pathway inhibitor-2 as a novel serodiagnostic marker for clear cell carcinoma of the ovary.
J Obstet Gynaecol Res. 2021 Sep;47(9):2978-2989. doi: 10.1111/jog.14916. Epub 2021 Jun 28. PMID: 34184357.

Kobayashi H, Imanaka S.
Proposal for developing treatment algorithms of women with symptomatic adenomyosis: A single-center experience.
J Obstet Gynaecol Res. 2021 Sep;47(9):3257-3268. doi: 10.1111/jog.14904. Epub 2021 Jun 21. PMID: 34155744.

Imanaka S, Yamada Y, Kawahara N, Kobayashi H.
Validation of magnetic resonance relaxometry R2 value and cyst fluid iron level for diagnosis of ovarian endometrioma.
Redox Rep. 2021 Dec;26(1):105-110. doi: 10.1080/13510002.2021.1937456. PMID: 34082665; PMCID: PMC8183507.

Kawahara N, Yamada Y, Kobayashi H.
CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma.
Int J Mol Sci. 2021 May 30;22(11):5869. doi: 10.3390/ijms22115869. PMID: 34070839; PMCID: PMC8198755.

Miyagi E, Arakawa N, Sakamaki K, Yokota NR, Yamanaka T, Yamada Y, Yamaguchi S, Nagao S, Hirashima Y, Kasamatsu Y, Kato H, Mogami T, Miyagi Y, Kobayashi H.
Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary.
Int J Clin Oncol. 2021 Jul;26(7):1336-1344. doi: 10.1007/s10147-021-01914-y. Epub 2021 May 19. PMID: 34009487; PMCID: PMC8213588.

Matsubara S, Mabuchi S, Takeda Y, Kawahara N, Kobayashi H.
Prognostic value of pre-treatment systemic immune-inflammation index in patients with endometrial cancer.
PLoS One. 2021 May 14;16(5):e0248871. doi: 10.1371/journal.pone.0248871. PMID: 33989285; PMCID: PMC8121307.

Kobayashi H, Matsubara S, Imanaka S.
Relationship between magnetic resonance imaging-based classification of adenomyosis and disease severity.
J Obstet Gynaecol Res. 2021 Jul;47(7):2251-2260. doi: 10.1111/jog.14803. Epub 2021 Apr 27. PMID: 33908135.

Imanaka S, Yamada Y, Kawahara N, Kobayashi H.
A delicate redox balance between iron and heme oxygenase-1 as an essential biological feature of endometriosis.
Arch Med Res. 2021 Aug;52(6):641-647. doi: 10.1016/j.arcmed.2021.03.006. Epub 2021 Apr 15. PMID: 33863580.

Imanaka S, Maruyama S, Kimura M, Nagayasu M, Kawahara N, Kobayashi H.
Relationship between Cyst Fluid Concentrations of Iron and Severity of Dysmenorrhea in Patients with Ovarian Endometrioma.
Gynecol Obstet Invest. 2021;86(1-2):185-192. doi: 10.1159/000514972. Epub 2021 Mar 29. PMID: 33780964.

Imanaka S, Shigetomi H, Kobayashi H.
Reprogramming of glucose metabolism of cumulus cells and oocytes and its therapeutic significance.
Reprod Sci. 2022 Mar;29(3):653-667. doi: 10.1007/s43032-021-00505-6. Epub 2021 Mar 5. PMID: 33675030.

Kobayashi H, Kimura M, Maruyama S, Nagayasu M, Imanaka S.
Revisiting estrogen-dependent signaling pathways in endometriosis: Potential targets for non-hormonal therapeutics.
Eur J Obstet Gynecol Reprod Biol. 2021 Mar;258:103-110. doi: 10.1016/j.ejogrb.2020.12.044. Epub 2020 Dec 29. PMID: 33421806.

Nagayasu M, Imanaka S, Kimura M, Maruyama S, Kobayashi H.
Nonhormonal Treatment for Endometriosis Focusing on Redox Imbalance.
Gynecol Obstet Invest. 2021;86(1-2):1-12. doi: 10.1159/000512628. Epub 2021 Jan 4. PMID: 33395684.

Kawaguchi R, Matsumoto K, Ishikawa T, Ishitani K, Okagaki R, Ogawa M, Oki T, Ozawa N, Kawasaki K, Kuwabara Y, Koga K, Sato Y, Takai Y, Tanaka K, Tanebe K, Terauchi M, Todo Y, Nose-Ogura S, Noda T, Baba T, Fujii E, Fujii T, Miyazaki H, Yoshino O, Yoshimura K, Maeda T, Kudo Y, Kobayashi H.
Guideline for Gynecological Practice in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2020 edition.
J Obstet Gynaecol Res. 2021 Jan;47(1):5-25. doi: 10.1111/jog.14487. Epub 2020 Nov 4. PMID: 33145837.

2020年

Kawahara N, Mizutani A, Matsubara S, Takeda Y, Kobayashi H.
GSK-3β mediates the effects of HNF-1β overexpression in ovarian clear cell carcinoma.
Exp Ther Med. 2020 Nov;20(5):122. doi: 10.3892/etm.2020.9250. Epub 2020 Sep 21. PMID: 33005248; PMCID: PMC7523276.

Naruse K, Yamashita T, Onishi Y, Niitaka Y, Uchida F, Kawahata K, Ishihara M, Kobayashi H.
High-Quality Transmission of Cardiotocogram and Fetal Information Using a 5G System: Pilot Experiment.
JMIR Med Inform. 2020 Sep 8;8(9):e19744. doi: 10.2196/19744. PMID: 32897237; PMCID: PMC7509628.

Maruyama S, Imanaka S, Nagayasu M, Kimura M, Kobayashi H.
Relationship between adenomyosis and endometriosis; Different phenotypes of a single disease?
Eur J Obstet Gynecol Reprod Biol. 2020 Oct;253:191-197. doi: 10.1016/j.ejogrb.2020.08.019. Epub 2020 Aug 23. PMID: 32877772.

Onishi T, Nogami K, Ishihara T, Inoue S, Kawaguchi M, Nishio K, Fukushima H, Kobayashi H, Amano I, Nishikubo T, Yamasaki M, Kasahara M, Shima M.
A Pathological Clarification of Sepsis-Associated Disseminated Intravascular Coagulation Based on Comprehensive Coagulation and Fibrinolysis Function.
Thromb Haemost. 2020 Sep;120(9):1257-1269. doi: 10.1055/s-0040-1713890. Epub 2020 Jul 17. PMID: 32679594.

Eura N, Matsui TK, Luginbühl J, Matsubayashi M, Nanaura H, Shiota T, Kinugawa K, Iguchi N, Kiriyama T, Zheng C, Kouno T, Lan YJ, Kongpracha P, Wiriyasermkul P, Sakaguchi YM, Nagata R, Komeda T, Morikawa N, Kitayoshi F, Jong M, Kobashigawa S, Nakanishi M, Hasegawa M, Saito Y, Shiromizu T, Nishimura Y, Kasai T, Takeda M, Kobayashi H, Inagaki Y, Tanaka Y, Makinodan M, Kishimoto T, Kuniyasu H, Nagamori S, Muotri AR, Shin JW, Sugie K, Mori E.
Brainstem Organoids From Human Pluripotent Stem Cells.
Front Neurosci. 2020 Jun 26;14:538. doi: 10.3389/fnins.2020.00538. PMID: 32670003; PMCID: PMC7332712.

Omokawa N, Mabuchi S, Iwai K, Kawahara N, Kawaguchi R, Sugimoto S, Ohbayashi C, Honoki K, Nagai A, Kobayashi H.
Skeletal muscle metastasis as a first site of recurrence of cervical cancer: A case report and review of the literature.
Medicine (Baltimore). 2020 May;99(19):e20056. doi: 10.1097/MD.0000000000020056. PMID: 32384470; PMCID: PMC7220549.

Kobayashi H, Matsubara S.
A Classification Proposal for Adenomyosis Based on Magnetic Resonance Imaging.
Gynecol Obstet Invest. 2020;85(2):118-126. doi: 10.1159/000505690. Epub 2020 Mar 11. PMID: 32160631.

Wakita Y, Takahama J, Yamauchi S, Okada H, Marugami N, Itoh T, Hirai T, Kichikawa K, Uchiyama T, Obayashi C, Matsubara S, Kobayashi H.
Uterine adenomatoid tumor associated with lymph node lesions: a case report.
Abdom Radiol (NY). 2020 Jul;45(7):2263-2267. doi: 10.1007/s00261-020-02439-0. PMID: 32060612.

Kobayashi H, Kawahara N, Ogawa K, Yoshimoto C.
A Relationship Between Endometriosis and Obstetric Complications.
Reprod Sci. 2020 Mar;27(3):771-778. doi: 10.1007/s43032-019-00118-0. Epub 2020 Jan 6. PMID: 32046459.

Kobayashi H, Kawahara N, Ogawa K, Yoshimoto C.
Shared Molecular Features Linking Endometriosis and Obstetric Complications.
Reprod Sci. 2020 May;27(5):1089-1096. doi: 10.1007/s43032-019-00119-z. Epub 2020 Jan 6. PMID: 32046439.

Kobayashi H, Kishi Y, Matsubara S.
Mechanisms Underlying Adenomyosis-Related Fibrogenesis.
Gynecol Obstet Invest. 2020;85(1):1-12. doi: 10.1159/000502822. Epub 2019 Sep 5. PMID: 31487711.

Yamada Y, Kawaguchi R, Iwai K, Niiro E, Morioka S, Tanase Y, Kobayashi H.
Preoperative plasma D-dimer level is a useful prognostic marker in ovarian cancer.
J Obstet Gynaecol. 2020 Jan;40(1):102-106. doi: 10.1080/01443615.2019.1606176. Epub 2019 Jul 23. PMID: 31335252.